aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Shuyuan Mo et al.|Journal of Hepatology|2020Cited by 346
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Ye Zhang, Zhaohui Zheng et al.|Signal Transduction and Targeted Therapy|2021Cited by 66
Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitisMengyuan Li, Jianqi Lian|Cell & Bioscience|2025Cited by 3